Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Pharm-country    crawled date : 2022 - 12 - 20    save search

Amneal Announces 26 Generic New Product Launches in 2022 and First Injection Large Volume Bag Approval
Published: 2022-12-20 (Crawled : 17:00) - biospace.com/
AMRX | $5.44 -1.81% -1.84% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.46% H: 0.47% C: -2.33%

approval injection
electroCore, Inc. Launches New Wellness Product Offering for Stress, Anxiety and Sleep, Truvaga™
Published: 2022-12-20 (Crawled : 17:00) - biospace.com/
ECOR | $5.57 -1.76% -1.8% 13K twitter stocktwits trandingview |
Health Technology
| | O: 5.84% H: 0.0% C: -11.43%

offering wellness
Cigna Corporation Announces Appearance at the 41st Annual J.P. Morgan Healthcare Conference
Published: 2022-12-20 (Crawled : 14:20) - biospace.com/
CI | $346.85 -0.59% 0.0% 1.8M twitter stocktwits trandingview |
Health Services
| | O: -0.05% H: 0.87% C: -0.33%

conference corporation
Iveric Bio Announces Completion of Rolling NDA Submission to FDA for Avacincaptad Pegol for the Treatment of Geographic Atrophy
Published: 2022-12-20 (Crawled : 13:20) - biospace.com/
ISEE | $39.95 0.38% 0.38% 0 twitter stocktwits trandingview |
Health Technology
| | O: -3.83% H: 5.88% C: 5.27%

treatment fda submission
Quantum-Si Announces Commercial Availability of PlatinumTM, the World’s First Next-Generation Single-Molecule Protein Sequencing Platform
Published: 2022-12-20 (Crawled : 13:20) - biospace.com/
QSI | $1.64 -1.21% -1.22% 580K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -0.53% H: 4.84% C: 0.54%

commercial platform
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer
Published: 2022-12-20 (Crawled : 13:20) - biospace.com/
GILD | $67.32 -0.64% -0.64% 5M twitter stocktwits trandingview |
Health Technology
| | O: -3.21% H: 1.93% C: 1.35%

acquire t-cell therapeutics therapy cancer
Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel
Published: 2022-12-20 (Crawled : 13:20) - biospace.com/
ATNX | $0.2031 -7.78% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: 118.18% H: 8.7% C: -42.03%

quantum trial leap positive
Gainers vs Losers
58% 42%

Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M twitter stocktwits trandingview |
Electronic Technology

VIAO | $0.265 -13.96% 35.85% 960K twitter stocktwits trandingview |
Electronic Technology

JAGX | $0.178 49.83% 33.26% 600M twitter stocktwits trandingview |
Health Technology

SXTC | $1.68 43.59% 30.36% 34M twitter stocktwits trandingview |
Health Technology

DYNT | $0.531 43.36% 30.24% 22M twitter stocktwits trandingview |
Health Technology

KA | $0.4796 41.06% 29.11% 5.3M twitter stocktwits trandingview |
Manufacturing

PALI | $5.86 40.87% 29.01% 29M twitter stocktwits trandingview |
Manufacturing

CLNN | $0.319 -3.74% 28.75% 6.3M twitter stocktwits trandingview |

BSGM | $1.52 38.18% 27.63% 3.3M twitter stocktwits trandingview |
Health Technology

MCBC | $13.67 37.66% 27.36% 2.2M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.